首页> 外文期刊>Chemistry, an Asian journal >Enantioselective Syntheses of Rigidiusculamides A and B: Revision of the Relative Stereochemistry of Rigidiusculamide A
【24h】

Enantioselective Syntheses of Rigidiusculamides A and B: Revision of the Relative Stereochemistry of Rigidiusculamide A

机译:刚性二甲酰胺A和B的对映选择性合成:刚性二甲酰胺A的相对立体化学的修订

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The first enantioselective synthesis of cytotoxic natural products rigidiusculamides A (ent-21) and B (8) has been achieved by two synthetic routes. The first one is convergent based on the common intermediate 11, obtained through a high yielding SmI_(2)-mediated Reformatsky-type reaction. A highly diastereoselective one-pot Dess-Martin periodinane-mediated bis-oxidation allowed the direct conversion of the diastereomeric mixture of 11 into rigidiusculamide B (8). Isolation of minor diastereomer 21, in combination with computational work, allowed us to suggest the structure of the natural rigidiusculamide A to be ent-21, as synthesized by the second route. Four diastereomers (7, ent-7, 22a, and 22b) and an enantiomer (21) of rigidiusculamide A (ent-21) have been synthesized. On the basis of literature precedents and computational work, a biosynthetic pathway for rigidiusculamides A and B was proposed to account for the opposite configuration at C-5 of those two congeners.
机译:细胞毒性天然产物刚性链霉菌酰胺A(ent-21)和B(8)的第一个对映选择性合成已通过两种合成途径实现。第一个是基于通用中间体11收敛的,该中间体是通过高收率SmI_(2)介导的Reformatsky型反应获得的。高度非对映选择性的一锅式Dess-Martin高碘素介导的双氧化可将11的非对映异构体混合物直接转化为刚性链霉菌素B(8)。较小的非对映异构体21的分离,结合计算工作,使我们提出了由第二种途径合成的天然刚性链霉酰胺A的结构为ent-21。合成了四种刚性非对酰胺A(对映体21)的非对映异构体(7、7-7、22a和22b)和对映体(21)。基于文献的先例和计算工作,提出了刚性链霉菌酰胺A和B的生物合成途径,以解释这两个同类物在C-5的相反构型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号